Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbutaline and Danazol for Steroid-resistant/Relapsed ITP
NCT04481282Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terbutaline in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
terbutaline
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04481282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481282.